Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cryo Cell International (CCEL) EPS (Weighted Average and Diluted) (2016 - 2026)

Cryo Cell International's EPS (Weighted Average and Diluted) history spans 17 years, with the latest figure at $0.01 for Q1 2026.

  • Quarterly results put EPS (Weighted Average and Diluted) at $0.01 for Q1 2026, down 66.67% from a year ago — trailing twelve months through Feb 2026 was -$0.33 (down 1750.0% YoY), and the annual figure for FY2025 was -$0.3, down 700.0%.
  • EPS (Weighted Average and Diluted) for Q1 2026 was $0.01 at Cryo Cell International, up from -$0.47 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.13 in Q3 2024 to a low of -$1.34 in Q4 2023.
  • The 5-year median for EPS (Weighted Average and Diluted) is $0.07 (2022), against an average of -$0.06.
  • The sharpest move saw EPS (Weighted Average and Diluted) surged 225.0% in 2022, then plummeted 1440.0% in 2023.
  • Year by year, EPS (Weighted Average and Diluted) stood at $0.1 in 2022, then plummeted by 1440.0% to -$1.34 in 2023, then soared by 83.58% to -$0.22 in 2024, then crashed by 113.64% to -$0.47 in 2025, then soared by 102.13% to $0.01 in 2026.
  • According to Business Quant data, EPS (Weighted Average and Diluted) over the past three periods came in at $0.01, -$0.47, and $0.09 for Q1 2026, Q4 2025, and Q3 2025 respectively.